⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of GNT Pharma and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
GNT Pharma
↗Yongin, South Korea
GNT Pharma is a South Korean biopharmaceutical company founded in 1998 by a group of neuroscience and pharmacology professors. The company specializes in the development of innovative, multi-targeting drugs for neurological, inflammatory, and respiratory disorders, with a primary focus on stroke and neurodegenerative diseases like Alzheimer's.
Their research approach centers on 'multi-targeting' mechanisms to protect brain cells from multiple concurrent disease pathways, such as excitotoxicity and oxidative stress. The company maintains operations in South Korea, Italy, and the USA, and has successfully commercialized veterinary products while advancing a late-stage human clinical pipeline.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:1998
Ownership:private
Status:operating
PIPELINE
Stage:Phase 3
Lead Drug Stage:Phase 3
Modalities:Small molecule
Active Trials:3
Trial Phases:Phase 1: 1 | Phase 2: 1 | Phase 3: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Yuhan Corporation (Commercialization of GedaCure in Korea), Sichuan Huiyu Pharmaceutical (cGMP manufacturing for Nelonemdaz)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Byoung Joo Gwag - CEO
Chun San An - Clinical Development Officer
Scientific Founders:Byoung Joo Gwag, Seung Up Kim, Cheol Kim, Jai Sung Noh, Eui Ju Choi, Young Joon Oh, Cheon Gi Joo, Sung Hwa Yoon
LINKS
Website:gntpharma.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with GNT Pharma. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.